nodes	percent_of_prediction	percent_of_DWPC	metapath
Desvenlafaxine—Cardiac disorder—Capecitabine—stomach cancer	0.00228	0.00228	CcSEcCtD
Desvenlafaxine—Chills—Docetaxel—stomach cancer	0.00227	0.00227	CcSEcCtD
Desvenlafaxine—Decreased appetite—Irinotecan—stomach cancer	0.00226	0.00226	CcSEcCtD
Desvenlafaxine—Orthostatic hypotension—Epirubicin—stomach cancer	0.00226	0.00226	CcSEcCtD
Desvenlafaxine—Insomnia—Fluorouracil—stomach cancer	0.00226	0.00226	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Irinotecan—stomach cancer	0.00225	0.00225	CcSEcCtD
Desvenlafaxine—Fatigue—Irinotecan—stomach cancer	0.00225	0.00225	CcSEcCtD
Desvenlafaxine—Paraesthesia—Fluorouracil—stomach cancer	0.00224	0.00224	CcSEcCtD
Desvenlafaxine—Alopecia—Docetaxel—stomach cancer	0.00224	0.00224	CcSEcCtD
Desvenlafaxine—Breast disorder—Epirubicin—stomach cancer	0.00223	0.00223	CcSEcCtD
Desvenlafaxine—Constipation—Irinotecan—stomach cancer	0.00223	0.00223	CcSEcCtD
Desvenlafaxine—Angiopathy—Capecitabine—stomach cancer	0.00223	0.00223	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Epirubicin—stomach cancer	0.00223	0.00223	CcSEcCtD
Desvenlafaxine—Mental disorder—Docetaxel—stomach cancer	0.00222	0.00222	CcSEcCtD
Desvenlafaxine—Somnolence—Fluorouracil—stomach cancer	0.00222	0.00222	CcSEcCtD
Desvenlafaxine—Immune system disorder—Capecitabine—stomach cancer	0.00222	0.00222	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Capecitabine—stomach cancer	0.00221	0.00221	CcSEcCtD
Desvenlafaxine—Malnutrition—Docetaxel—stomach cancer	0.00221	0.00221	CcSEcCtD
Desvenlafaxine—Chills—Capecitabine—stomach cancer	0.0022	0.0022	CcSEcCtD
Desvenlafaxine—Decreased appetite—Fluorouracil—stomach cancer	0.00217	0.00217	CcSEcCtD
Desvenlafaxine—Alopecia—Capecitabine—stomach cancer	0.00217	0.00217	CcSEcCtD
Desvenlafaxine—Dysgeusia—Docetaxel—stomach cancer	0.00216	0.00216	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.00215	0.00215	CcSEcCtD
Desvenlafaxine—Mental disorder—Capecitabine—stomach cancer	0.00215	0.00215	CcSEcCtD
Desvenlafaxine—Malnutrition—Capecitabine—stomach cancer	0.00214	0.00214	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Doxorubicin—stomach cancer	0.00211	0.00211	CcSEcCtD
Desvenlafaxine—Erectile dysfunction—Methotrexate—stomach cancer	0.0021	0.0021	CcSEcCtD
Desvenlafaxine—Dysgeusia—Capecitabine—stomach cancer	0.00209	0.00209	CcSEcCtD
Desvenlafaxine—Orthostatic hypotension—Doxorubicin—stomach cancer	0.00209	0.00209	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Methotrexate—stomach cancer	0.00208	0.00208	CcSEcCtD
Desvenlafaxine—Breast disorder—Doxorubicin—stomach cancer	0.00207	0.00207	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Doxorubicin—stomach cancer	0.00206	0.00206	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Methotrexate—stomach cancer	0.00202	0.00202	CcSEcCtD
Desvenlafaxine—Vision blurred—Capecitabine—stomach cancer	0.00201	0.00201	CcSEcCtD
Desvenlafaxine—Tremor—Capecitabine—stomach cancer	0.002	0.002	CcSEcCtD
Desvenlafaxine—Syncope—Docetaxel—stomach cancer	0.00198	0.00198	CcSEcCtD
Desvenlafaxine—Palpitations—Docetaxel—stomach cancer	0.00195	0.00195	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Epirubicin—stomach cancer	0.00195	0.00195	CcSEcCtD
Desvenlafaxine—Weight increased—Epirubicin—stomach cancer	0.00194	0.00194	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Docetaxel—stomach cancer	0.00194	0.00194	CcSEcCtD
Desvenlafaxine—Weight decreased—Epirubicin—stomach cancer	0.00193	0.00193	CcSEcCtD
Desvenlafaxine—Epistaxis—Methotrexate—stomach cancer	0.00192	0.00192	CcSEcCtD
Desvenlafaxine—Vertigo—Capecitabine—stomach cancer	0.00192	0.00192	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Irinotecan—stomach cancer	0.00192	0.00192	CcSEcCtD
Desvenlafaxine—Syncope—Capecitabine—stomach cancer	0.00192	0.00192	CcSEcCtD
Desvenlafaxine—Convulsion—Docetaxel—stomach cancer	0.00191	0.00191	CcSEcCtD
Desvenlafaxine—Hypertension—Docetaxel—stomach cancer	0.00191	0.00191	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.00189	0.00189	CcSEcCtD
Desvenlafaxine—Palpitations—Capecitabine—stomach cancer	0.00189	0.00189	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Capecitabine—stomach cancer	0.00188	0.00188	CcSEcCtD
Desvenlafaxine—Asthenia—Irinotecan—stomach cancer	0.00187	0.00187	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.00187	0.00187	CcSEcCtD
Desvenlafaxine—Hypertension—Capecitabine—stomach cancer	0.00184	0.00184	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Fluorouracil—stomach cancer	0.00184	0.00184	CcSEcCtD
Desvenlafaxine—Dry mouth—Docetaxel—stomach cancer	0.00184	0.00184	CcSEcCtD
Desvenlafaxine—Anxiety—Capecitabine—stomach cancer	0.00181	0.00181	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.00181	0.00181	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Methotrexate—stomach cancer	0.0018	0.0018	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Doxorubicin—stomach cancer	0.0018	0.0018	CcSEcCtD
Desvenlafaxine—Weight increased—Doxorubicin—stomach cancer	0.0018	0.0018	CcSEcCtD
Desvenlafaxine—Epistaxis—Epirubicin—stomach cancer	0.0018	0.0018	CcSEcCtD
Desvenlafaxine—Urethral disorder—Methotrexate—stomach cancer	0.00179	0.00179	CcSEcCtD
Desvenlafaxine—Weight decreased—Doxorubicin—stomach cancer	0.00179	0.00179	CcSEcCtD
Desvenlafaxine—Diarrhoea—Irinotecan—stomach cancer	0.00178	0.00178	CcSEcCtD
Desvenlafaxine—Dry mouth—Capecitabine—stomach cancer	0.00178	0.00178	CcSEcCtD
Desvenlafaxine—Shock—Docetaxel—stomach cancer	0.00177	0.00177	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Docetaxel—stomach cancer	0.00177	0.00177	CcSEcCtD
Desvenlafaxine—Tachycardia—Docetaxel—stomach cancer	0.00176	0.00176	CcSEcCtD
Desvenlafaxine—Skin disorder—Docetaxel—stomach cancer	0.00175	0.00175	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.00175	0.00175	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Methotrexate—stomach cancer	0.00173	0.00173	CcSEcCtD
Desvenlafaxine—Dizziness—Irinotecan—stomach cancer	0.00172	0.00172	CcSEcCtD
Desvenlafaxine—Shock—Capecitabine—stomach cancer	0.00172	0.00172	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Capecitabine—stomach cancer	0.00171	0.00171	CcSEcCtD
Desvenlafaxine—Eye disorder—Methotrexate—stomach cancer	0.00171	0.00171	CcSEcCtD
Desvenlafaxine—Diarrhoea—Fluorouracil—stomach cancer	0.00171	0.00171	CcSEcCtD
Desvenlafaxine—Tinnitus—Methotrexate—stomach cancer	0.0017	0.0017	CcSEcCtD
Desvenlafaxine—Tachycardia—Capecitabine—stomach cancer	0.0017	0.0017	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Methotrexate—stomach cancer	0.0017	0.0017	CcSEcCtD
Desvenlafaxine—Skin disorder—Capecitabine—stomach cancer	0.00169	0.00169	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Epirubicin—stomach cancer	0.00169	0.00169	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Capecitabine—stomach cancer	0.00169	0.00169	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Epirubicin—stomach cancer	0.00168	0.00168	CcSEcCtD
Desvenlafaxine—Urethral disorder—Epirubicin—stomach cancer	0.00168	0.00168	CcSEcCtD
Desvenlafaxine—Epistaxis—Doxorubicin—stomach cancer	0.00166	0.00166	CcSEcCtD
Desvenlafaxine—Angiopathy—Methotrexate—stomach cancer	0.00166	0.00166	CcSEcCtD
Desvenlafaxine—Vomiting—Irinotecan—stomach cancer	0.00166	0.00166	CcSEcCtD
Desvenlafaxine—Immune system disorder—Methotrexate—stomach cancer	0.00165	0.00165	CcSEcCtD
Desvenlafaxine—Dizziness—Fluorouracil—stomach cancer	0.00165	0.00165	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Methotrexate—stomach cancer	0.00165	0.00165	CcSEcCtD
Desvenlafaxine—Rash—Irinotecan—stomach cancer	0.00164	0.00164	CcSEcCtD
Desvenlafaxine—Dermatitis—Irinotecan—stomach cancer	0.00164	0.00164	CcSEcCtD
Desvenlafaxine—Chills—Methotrexate—stomach cancer	0.00164	0.00164	CcSEcCtD
Desvenlafaxine—Headache—Irinotecan—stomach cancer	0.00163	0.00163	CcSEcCtD
Desvenlafaxine—Insomnia—Docetaxel—stomach cancer	0.00163	0.00163	CcSEcCtD
Desvenlafaxine—Paraesthesia—Docetaxel—stomach cancer	0.00162	0.00162	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Epirubicin—stomach cancer	0.00162	0.00162	CcSEcCtD
Desvenlafaxine—Alopecia—Methotrexate—stomach cancer	0.00161	0.00161	CcSEcCtD
Desvenlafaxine—Somnolence—Docetaxel—stomach cancer	0.0016	0.0016	CcSEcCtD
Desvenlafaxine—Mental disorder—Methotrexate—stomach cancer	0.0016	0.0016	CcSEcCtD
Desvenlafaxine—Eye disorder—Epirubicin—stomach cancer	0.0016	0.0016	CcSEcCtD
Desvenlafaxine—Tinnitus—Epirubicin—stomach cancer	0.00159	0.00159	CcSEcCtD
Desvenlafaxine—Malnutrition—Methotrexate—stomach cancer	0.00159	0.00159	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Epirubicin—stomach cancer	0.00159	0.00159	CcSEcCtD
Desvenlafaxine—Vomiting—Fluorouracil—stomach cancer	0.00159	0.00159	CcSEcCtD
Desvenlafaxine—Insomnia—Capecitabine—stomach cancer	0.00158	0.00158	CcSEcCtD
Desvenlafaxine—Rash—Fluorouracil—stomach cancer	0.00157	0.00157	CcSEcCtD
Desvenlafaxine—Dermatitis—Fluorouracil—stomach cancer	0.00157	0.00157	CcSEcCtD
Desvenlafaxine—Paraesthesia—Capecitabine—stomach cancer	0.00157	0.00157	CcSEcCtD
Desvenlafaxine—Decreased appetite—Docetaxel—stomach cancer	0.00157	0.00157	CcSEcCtD
Desvenlafaxine—Headache—Fluorouracil—stomach cancer	0.00156	0.00156	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Doxorubicin—stomach cancer	0.00156	0.00156	CcSEcCtD
Desvenlafaxine—Dysgeusia—Methotrexate—stomach cancer	0.00156	0.00156	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00155	0.00155	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Doxorubicin—stomach cancer	0.00155	0.00155	CcSEcCtD
Desvenlafaxine—Fatigue—Docetaxel—stomach cancer	0.00155	0.00155	CcSEcCtD
Desvenlafaxine—Angiopathy—Epirubicin—stomach cancer	0.00155	0.00155	CcSEcCtD
Desvenlafaxine—Urethral disorder—Doxorubicin—stomach cancer	0.00155	0.00155	CcSEcCtD
Desvenlafaxine—Nausea—Irinotecan—stomach cancer	0.00155	0.00155	CcSEcCtD
Desvenlafaxine—Immune system disorder—Epirubicin—stomach cancer	0.00154	0.00154	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Epirubicin—stomach cancer	0.00154	0.00154	CcSEcCtD
Desvenlafaxine—Constipation—Docetaxel—stomach cancer	0.00154	0.00154	CcSEcCtD
Desvenlafaxine—Chills—Epirubicin—stomach cancer	0.00153	0.00153	CcSEcCtD
Desvenlafaxine—Decreased appetite—Capecitabine—stomach cancer	0.00152	0.00152	CcSEcCtD
Desvenlafaxine—Alopecia—Epirubicin—stomach cancer	0.00151	0.00151	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.00151	0.00151	CcSEcCtD
Desvenlafaxine—Fatigue—Capecitabine—stomach cancer	0.0015	0.0015	CcSEcCtD
Desvenlafaxine—Vision blurred—Methotrexate—stomach cancer	0.0015	0.0015	CcSEcCtD
Desvenlafaxine—Mental disorder—Epirubicin—stomach cancer	0.0015	0.0015	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Doxorubicin—stomach cancer	0.0015	0.0015	CcSEcCtD
Desvenlafaxine—Constipation—Capecitabine—stomach cancer	0.00149	0.00149	CcSEcCtD
Desvenlafaxine—Malnutrition—Epirubicin—stomach cancer	0.00149	0.00149	CcSEcCtD
Desvenlafaxine—Nausea—Fluorouracil—stomach cancer	0.00148	0.00148	CcSEcCtD
Desvenlafaxine—Eye disorder—Doxorubicin—stomach cancer	0.00148	0.00148	CcSEcCtD
Desvenlafaxine—Tinnitus—Doxorubicin—stomach cancer	0.00147	0.00147	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Doxorubicin—stomach cancer	0.00147	0.00147	CcSEcCtD
Desvenlafaxine—Tension—Epirubicin—stomach cancer	0.00146	0.00146	CcSEcCtD
Desvenlafaxine—Dysgeusia—Epirubicin—stomach cancer	0.00146	0.00146	CcSEcCtD
Desvenlafaxine—Nervousness—Epirubicin—stomach cancer	0.00145	0.00145	CcSEcCtD
Desvenlafaxine—Angiopathy—Doxorubicin—stomach cancer	0.00144	0.00144	CcSEcCtD
Desvenlafaxine—Immune system disorder—Doxorubicin—stomach cancer	0.00143	0.00143	CcSEcCtD
Desvenlafaxine—Vertigo—Methotrexate—stomach cancer	0.00143	0.00143	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Doxorubicin—stomach cancer	0.00143	0.00143	CcSEcCtD
Desvenlafaxine—Chills—Doxorubicin—stomach cancer	0.00142	0.00142	CcSEcCtD
Desvenlafaxine—Vision blurred—Epirubicin—stomach cancer	0.0014	0.0014	CcSEcCtD
Desvenlafaxine—Alopecia—Doxorubicin—stomach cancer	0.0014	0.0014	CcSEcCtD
Desvenlafaxine—Mental disorder—Doxorubicin—stomach cancer	0.00139	0.00139	CcSEcCtD
Desvenlafaxine—Convulsion—Methotrexate—stomach cancer	0.00138	0.00138	CcSEcCtD
Desvenlafaxine—Malnutrition—Doxorubicin—stomach cancer	0.00138	0.00138	CcSEcCtD
Desvenlafaxine—Tension—Doxorubicin—stomach cancer	0.00135	0.00135	CcSEcCtD
Desvenlafaxine—Dysgeusia—Doxorubicin—stomach cancer	0.00135	0.00135	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.00134	0.00134	CcSEcCtD
Desvenlafaxine—Nervousness—Doxorubicin—stomach cancer	0.00134	0.00134	CcSEcCtD
Desvenlafaxine—Vertigo—Epirubicin—stomach cancer	0.00134	0.00134	CcSEcCtD
Desvenlafaxine—Syncope—Epirubicin—stomach cancer	0.00133	0.00133	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Docetaxel—stomach cancer	0.00133	0.00133	CcSEcCtD
Desvenlafaxine—Palpitations—Epirubicin—stomach cancer	0.00132	0.00132	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Epirubicin—stomach cancer	0.00131	0.00131	CcSEcCtD
Desvenlafaxine—Vision blurred—Doxorubicin—stomach cancer	0.0013	0.0013	CcSEcCtD
Desvenlafaxine—Asthenia—Docetaxel—stomach cancer	0.00129	0.00129	CcSEcCtD
Desvenlafaxine—Convulsion—Epirubicin—stomach cancer	0.00129	0.00129	CcSEcCtD
Desvenlafaxine—Hypertension—Epirubicin—stomach cancer	0.00128	0.00128	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Capecitabine—stomach cancer	0.00128	0.00128	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Methotrexate—stomach cancer	0.00127	0.00127	CcSEcCtD
Desvenlafaxine—Anxiety—Epirubicin—stomach cancer	0.00126	0.00126	CcSEcCtD
Desvenlafaxine—Skin disorder—Methotrexate—stomach cancer	0.00126	0.00126	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.00126	0.00126	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Methotrexate—stomach cancer	0.00125	0.00125	CcSEcCtD
Desvenlafaxine—Asthenia—Capecitabine—stomach cancer	0.00125	0.00125	CcSEcCtD
Desvenlafaxine—Dry mouth—Epirubicin—stomach cancer	0.00124	0.00124	CcSEcCtD
Desvenlafaxine—Vertigo—Doxorubicin—stomach cancer	0.00124	0.00124	CcSEcCtD
Desvenlafaxine—Syncope—Doxorubicin—stomach cancer	0.00123	0.00123	CcSEcCtD
Desvenlafaxine—Diarrhoea—Docetaxel—stomach cancer	0.00123	0.00123	CcSEcCtD
Desvenlafaxine—Palpitations—Doxorubicin—stomach cancer	0.00122	0.00122	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Doxorubicin—stomach cancer	0.00121	0.00121	CcSEcCtD
Desvenlafaxine—Shock—Epirubicin—stomach cancer	0.0012	0.0012	CcSEcCtD
Desvenlafaxine—Convulsion—Doxorubicin—stomach cancer	0.00119	0.00119	CcSEcCtD
Desvenlafaxine—Diarrhoea—Capecitabine—stomach cancer	0.00119	0.00119	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Epirubicin—stomach cancer	0.00119	0.00119	CcSEcCtD
Desvenlafaxine—Dizziness—Docetaxel—stomach cancer	0.00119	0.00119	CcSEcCtD
Desvenlafaxine—Hypertension—Doxorubicin—stomach cancer	0.00119	0.00119	CcSEcCtD
Desvenlafaxine—Tachycardia—Epirubicin—stomach cancer	0.00119	0.00119	CcSEcCtD
Desvenlafaxine—Skin disorder—Epirubicin—stomach cancer	0.00118	0.00118	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Epirubicin—stomach cancer	0.00117	0.00117	CcSEcCtD
Desvenlafaxine—Insomnia—Methotrexate—stomach cancer	0.00117	0.00117	CcSEcCtD
Desvenlafaxine—Anxiety—Doxorubicin—stomach cancer	0.00117	0.00117	CcSEcCtD
Desvenlafaxine—Paraesthesia—Methotrexate—stomach cancer	0.00117	0.00117	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.00116	0.00116	CcSEcCtD
Desvenlafaxine—Somnolence—Methotrexate—stomach cancer	0.00115	0.00115	CcSEcCtD
Desvenlafaxine—Dizziness—Capecitabine—stomach cancer	0.00115	0.00115	CcSEcCtD
Desvenlafaxine—Dry mouth—Doxorubicin—stomach cancer	0.00115	0.00115	CcSEcCtD
Desvenlafaxine—Vomiting—Docetaxel—stomach cancer	0.00114	0.00114	CcSEcCtD
Desvenlafaxine—Rash—Docetaxel—stomach cancer	0.00114	0.00114	CcSEcCtD
Desvenlafaxine—Dermatitis—Docetaxel—stomach cancer	0.00113	0.00113	CcSEcCtD
Desvenlafaxine—Decreased appetite—Methotrexate—stomach cancer	0.00113	0.00113	CcSEcCtD
Desvenlafaxine—Headache—Docetaxel—stomach cancer	0.00113	0.00113	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Methotrexate—stomach cancer	0.00112	0.00112	CcSEcCtD
Desvenlafaxine—Fatigue—Methotrexate—stomach cancer	0.00112	0.00112	CcSEcCtD
Desvenlafaxine—Vomiting—Capecitabine—stomach cancer	0.00111	0.00111	CcSEcCtD
Desvenlafaxine—Shock—Doxorubicin—stomach cancer	0.00111	0.00111	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Doxorubicin—stomach cancer	0.0011	0.0011	CcSEcCtD
Desvenlafaxine—Rash—Capecitabine—stomach cancer	0.0011	0.0011	CcSEcCtD
Desvenlafaxine—Insomnia—Epirubicin—stomach cancer	0.0011	0.0011	CcSEcCtD
Desvenlafaxine—Dermatitis—Capecitabine—stomach cancer	0.0011	0.0011	CcSEcCtD
Desvenlafaxine—Tachycardia—Doxorubicin—stomach cancer	0.0011	0.0011	CcSEcCtD
Desvenlafaxine—Headache—Capecitabine—stomach cancer	0.00109	0.00109	CcSEcCtD
Desvenlafaxine—Skin disorder—Doxorubicin—stomach cancer	0.00109	0.00109	CcSEcCtD
Desvenlafaxine—Paraesthesia—Epirubicin—stomach cancer	0.00109	0.00109	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Doxorubicin—stomach cancer	0.00109	0.00109	CcSEcCtD
Desvenlafaxine—Somnolence—Epirubicin—stomach cancer	0.00108	0.00108	CcSEcCtD
Desvenlafaxine—Nausea—Docetaxel—stomach cancer	0.00107	0.00107	CcSEcCtD
Desvenlafaxine—Decreased appetite—Epirubicin—stomach cancer	0.00106	0.00106	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Epirubicin—stomach cancer	0.00105	0.00105	CcSEcCtD
Desvenlafaxine—Fatigue—Epirubicin—stomach cancer	0.00105	0.00105	CcSEcCtD
Desvenlafaxine—Constipation—Epirubicin—stomach cancer	0.00104	0.00104	CcSEcCtD
Desvenlafaxine—Nausea—Capecitabine—stomach cancer	0.00104	0.00104	CcSEcCtD
Desvenlafaxine—Insomnia—Doxorubicin—stomach cancer	0.00102	0.00102	CcSEcCtD
Desvenlafaxine—Paraesthesia—Doxorubicin—stomach cancer	0.00101	0.00101	CcSEcCtD
Desvenlafaxine—Somnolence—Doxorubicin—stomach cancer	0.000999	0.000999	CcSEcCtD
Desvenlafaxine—Decreased appetite—Doxorubicin—stomach cancer	0.000977	0.000977	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.00097	0.00097	CcSEcCtD
Desvenlafaxine—Fatigue—Doxorubicin—stomach cancer	0.000969	0.000969	CcSEcCtD
Desvenlafaxine—Constipation—Doxorubicin—stomach cancer	0.000961	0.000961	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Methotrexate—stomach cancer	0.000956	0.000956	CcSEcCtD
Desvenlafaxine—Asthenia—Methotrexate—stomach cancer	0.000931	0.000931	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Epirubicin—stomach cancer	0.000895	0.000895	CcSEcCtD
Desvenlafaxine—Diarrhoea—Methotrexate—stomach cancer	0.000888	0.000888	CcSEcCtD
Desvenlafaxine—Asthenia—Epirubicin—stomach cancer	0.000871	0.000871	CcSEcCtD
Desvenlafaxine—Dizziness—Methotrexate—stomach cancer	0.000858	0.000858	CcSEcCtD
Desvenlafaxine—Diarrhoea—Epirubicin—stomach cancer	0.000831	0.000831	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Doxorubicin—stomach cancer	0.000828	0.000828	CcSEcCtD
Desvenlafaxine—Vomiting—Methotrexate—stomach cancer	0.000825	0.000825	CcSEcCtD
Desvenlafaxine—Rash—Methotrexate—stomach cancer	0.000818	0.000818	CcSEcCtD
Desvenlafaxine—Dermatitis—Methotrexate—stomach cancer	0.000818	0.000818	CcSEcCtD
Desvenlafaxine—Headache—Methotrexate—stomach cancer	0.000813	0.000813	CcSEcCtD
Desvenlafaxine—Asthenia—Doxorubicin—stomach cancer	0.000806	0.000806	CcSEcCtD
Desvenlafaxine—Dizziness—Epirubicin—stomach cancer	0.000803	0.000803	CcSEcCtD
Desvenlafaxine—Vomiting—Epirubicin—stomach cancer	0.000772	0.000772	CcSEcCtD
Desvenlafaxine—Nausea—Methotrexate—stomach cancer	0.000771	0.000771	CcSEcCtD
Desvenlafaxine—Diarrhoea—Doxorubicin—stomach cancer	0.000769	0.000769	CcSEcCtD
Desvenlafaxine—Rash—Epirubicin—stomach cancer	0.000766	0.000766	CcSEcCtD
Desvenlafaxine—Dermatitis—Epirubicin—stomach cancer	0.000765	0.000765	CcSEcCtD
Desvenlafaxine—Headache—Epirubicin—stomach cancer	0.000761	0.000761	CcSEcCtD
Desvenlafaxine—Dizziness—Doxorubicin—stomach cancer	0.000743	0.000743	CcSEcCtD
Desvenlafaxine—Nausea—Epirubicin—stomach cancer	0.000721	0.000721	CcSEcCtD
Desvenlafaxine—Vomiting—Doxorubicin—stomach cancer	0.000715	0.000715	CcSEcCtD
Desvenlafaxine—Rash—Doxorubicin—stomach cancer	0.000709	0.000709	CcSEcCtD
Desvenlafaxine—Dermatitis—Doxorubicin—stomach cancer	0.000708	0.000708	CcSEcCtD
Desvenlafaxine—Headache—Doxorubicin—stomach cancer	0.000704	0.000704	CcSEcCtD
Desvenlafaxine—Nausea—Doxorubicin—stomach cancer	0.000668	0.000668	CcSEcCtD
